Congenital Anomalies and Resource Utilization in Neonates Infected With Herpes Simplex Virus
- 1 November 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 36 (11) , 680-685
- https://doi.org/10.1097/olq.0b013e3181aaf54f
Abstract
Background: Neonatal herpes simplex virus (HSV) infection, while uncommon, is associated with substantial morbidity and mortality. However, there is little nationally representative data describing resource utilization. Methods: This retrospective cohort study was conducted using the Pediatric Health Information System, an administrative database that contains discharge diagnosis and resource utilization data from 35 free-standing children’s hospitals. Patients ≤60 days of age with a primary discharge diagnosis of HSV were study eligible if they received intravenous acyclovir and were discharged between January 1, 2003 and December 31, 2005. Results: There were 406 patients with HSV. The median age was 16 days (interquartile range: 8–31 days); 52% of patients were female. Congenital heart disease, the most common congenital anomaly, occurred in 10% of patients. The median length of stay was 15 days; 21 (5%) patients died. HSV was associated with substantial resource utilization. The median hospital charge was $37,431 (interquartile range: $14,667–$74,559) per infant. The presence of congenital heart disease independently increased the hospital length of stay by 93% (adjusted LOS ratio: 1.93; 95% CI: 1.5–2.5). Conclusions: HSV infection in neonates and young infants was associated with substantial resource utilization. The presence of an underlying congenital cardiac anomaly was associated with a significantly longer length of stay and higher hospital charges.Keywords
This publication has 18 references indexed in Scilit:
- The Public Health Imperative for a Neonatal Herpes Simplex Virus Infection Surveillance SystemSexually Transmitted Diseases, 2006
- The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus–1 and –2 antibodiesAmerican Journal of Obstetrics and Gynecology, 2005
- Neonatal herpes: What have we learnedSeminars in Pediatric Infectious Diseases, 2005
- Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancyAmerican Journal of Obstetrics and Gynecology, 2004
- Mortality Associated With Congenital Heart Defects in the United StatesCirculation, 2001
- Management of herpes in pregnancyInternational Journal of Gynecology & Obstetrics, 2000
- Respiratory syncytial virus infection in children with congenital heart disease: A reviewPediatric Cardiology, 1996
- Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models.Psychological Bulletin, 1995
- The Risk of Determining Risk with Multivariable ModelsAnnals of Internal Medicine, 1993
- Respiratory Syncytial Viral Infection in Infants with Congenital Heart DiseaseNew England Journal of Medicine, 1982